Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat

Journal of Hypertension

Volumn 16, Issue 12, 1998, Pages 1813-1822

  Chung, Eugene S ^a   Perlini, Stefano ^b   Aurigemma, Gerard R ^a   Fenton, Richard A ^a   Dobson Jr , James G ^a   Meyer, Theo E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Adenosine; Diastolic dysfunction; Dipyridamole; Heart failure; Hypertension; Hypertrophy

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; DIPYRIDAMOLE; ISOPRENALINE; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HYPERTROPHY; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0031792946     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816120-00015     Document Type: Article

References (51)

1. Breisch EA, White FC, Bloor CM. Myocardial characteristics of pressure overload hypertrophy. Lab Invest 1984; 51:333-342.
2. Vatner SF. Reduced subendocardial myocardial perfusion as one mechanism for congestive heart failure. Am J Cardiol 1988; 62:94E-98E.
3. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar Collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989; 64:1041-1050.
4. Fouad FM, Slominski JM, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol 1984; 3:1500-1506.
5. Dhalla AK, Hill MF, Singal PK. Role of oxldative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996; 28:506-514.
6. Nyquist-Battie C, Cochran PK, Evans VR, Hitchcock JM, Unal C. Regulation of sympathetic presynaptic components in rat left ventricle during ligation of abdominal aorta. Am J Physiol 1996; 271:H1547-H1554.
7. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996; 93:1667-1676.
8. Sato N, Vatner SF, Shen Y-T, Kudej RK, Ghaleh-Marzban B, Uechi M, et al. Effects of cardiac denervation on development of heart failure and catecholamine desensitization. Circulation 1997; 95:2130-2140.
9. Schunkert H, Jackson B, Tang SS, Schoen FJ, Smits JF, Apstein CS, et al. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation 1993; 87:1328-1339.
10. Ferrari R, Bachitti T, Confortini R, Opasich C, Febo O, Corti A, et al. Tumor necrosis factor soluble receptors in patients with degrees of congestive heart failure. Circulation 1995; 92:1479-1486.
11. Rongen GA, Lenders JWM, Lambrou J, Willemsen J, Van Belle H, Thien T, et al. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension 1996; 27:933-938.
12. Dobson JG Jr, Ordway RW, Fenton RA. Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol 1986; 251:H455-H462.
13. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Progr Cardiovasc Dis 1989; 32:73-97.
14. Mattfeldt T, Mall G. Dipyridamole-induced capillary endothelial cell proliferation in the rat heart: a morphometric investigation. Cardiovasc Res 1983; 17:229-237.
15. Dubey RK, Gillespie DG, Mi Z, Jackson EK. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors. Circulation 1997; 96:2656-2666.
16. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992; 85:893-904.
17. Lagerkranser M, Sollevi A, Irestedt L, Tidgren B, Andreen M. Renin release during controlled hypotension with sodium nitroprusside, nitroglycerin and adenosine: a comparative study in the dog. Acta Anaesthesiol Scand 1985; 29:45-49.
18. Parmely MJ, Zhou WW, Edwards CK 3rd, Borcherding DR, Silverstein R, Morrison DC. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol 1993; 151:389-396.
19. Belardinelli L, Fenton RA, West G, Linden J, Althaus JS, Berne RM. Extracellular actions of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ Res 1982; 51:569-579.
20. Institute of Laboratory Animal Resources. Guide for the care and use of laboratory animals. Washington, DC: National Institutes of Health Publ No 85-23, US Department of Health, Education, and Welfare; 1996.
21. Fenton RA, Dobson JG Jr. Measurement by fluorescence of interstitial adenosine levels in normoxic, hypoxic, and ischemic perfused rat hearts. Circ Res 1987; 60:177-184.
22. Fenton RA, Dobson JG Jr. Fluorometric quantitation of adenosine concentration in small samples of extracellular fluid. Anal Biochem 1992; 207:134-141.
23. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994; 89:345-354.
24. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
25. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
26. Shimizu G, Zile MR, Blaustein AS, Gaasch WH. Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: overestimation of fiber velocities by conventional midwall measurements. Circulation 1985; 71:266-272.
27. Gaasch WH, Zile MR, Hoshino PK, Apstein CS, Blaustein AS. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 1989; 79:872-883.
28. Kolassa N, Pfleger K, Traam M. Species differences in action and elimination of adenosine after dipyridamole and hexobendine. Eur J Pharmacol 1971; 13:320-325.
29. 1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 1988; 337:687-689.
30. Perlini S, Khoury EP, Norton GR, Chung ES, Fenton RA, Dobson JG Jr, et al. Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. Circ Res 1998; 83:761-771.
31. Van Belle H, Janssen PAJ. Comparative pharmacology of nucleoside transport inhibitors. Nucleosides Nucleotides 1991; 10:975-982.
32. Van Belle H. Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine. Cardiovasc Res 1993; 27:68-76.
33. Froldi G, Belardinelli L. Species-dependent effects of adenosine on heart rate and atrioventricular nodal conduction: mechanism and physiologic implications. Circ Res 1990; 67:960-978.
34. Meghji P, Skladanowski AC, Newby AC, Slakey LL, Pearson JD. Effect of 5′-deoxy-5′-isobutylthioadenosine on formation and release of adenosine from neonatal and adult rat ventricular myocytes. Biochem J 1993; 291:833-839.
35. Ethier MF, Chander V, Dobson JG Jr. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol 1993; 265:H131-H138.
36. Sparks HV Jr, Dewill DF, Wangler RD, Gorman MW, Bassingthwaighte JB. Capillary transport of adenosine. Fed Proc 1985; 44:2620-2622.
37. Parsons WJ, Stiles GL Heterologous desensitization of the inhibitory A1 adenosine receptor adenylate cyclase system in rat adipocytes. J Biol Chem 1986;262:841-847.
38. Lee HT, Thompson CI, Hernandez A, Lewy JL, Belloni FL. Cardiac desensitization to adenosine analogues after prolonged R-PIA infusion in vivo. Am J Physiol 1993; 265:H1916-H1927.
39. Casati C, Monopoli A, Dionisotti S, Zocchi C, Bonizzoni E, Ongini E. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects. J Pharmacol Exp Ther 1994; 268:1506-1511.
40. Meyer TE, Chung ES, Perlini S, Norton GR, Fenton RA, Dobson JG. Myocardial adenosine concentrations first increase and then decrease during the transition from compensated LV hypertrophy to myocardial failure [abstract]. In: 70th Scientific Sessions of the AHA, Orlando, FL, 1997. Orlando, Florida: American Heart Association; pp. I267.
41. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Circulation 1995; 91:2642-2645.
42. Ahn HS, Crim W, Romano M, Sybertz E, Pitts E. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta. Biochem Pharmacol 1989; 38:3331-3339.
43. Bishop SP, Sole MJ, Tilley LP. Cardiomyopathies. In: Andrews C, Ward B, Altman N (editors): Spontaneous animal models of human disease. New York: Academic Press; 1979. pp. 59-64.
44. Ostman-Smith I. Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy. Clin Sci 1981; 1:265-272.
45. Rona G, Chappel CI, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 1959; 67:443-455.
46. Communal C, Singh K, Pimental DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 1998; 98:1329-1334.
47. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819-823.
48. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skeri L, Klein JW, et al. β-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 1992; 89:803-815.
49. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334:1349-1355.
50. Heilbrunn SM, Shar P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989; 79:483-490.
51. 1 receptor and pertussis toxin-sensitive G protein on the ferret ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 1993; 348:282-289.